-
PAI Partners to exit ADB Safegate, a global Airport Performance Solutions provider
When we acquired ADB in 2013, it was a leading player in airfield ground lighting. Four years later, through organic initiatives and the transformational combination with Safegate, the group has become the global leader in airfield guidance systems, providing airports worldwide with unique end-to-end airfield management solutions.Read more -
PAI Partners enters into exclusive negotiations for the sale of a majority stake in DomusVi
Under PAI’s ownership, the company has transformed from a French nursing home operator into a European leader across all areas of elderly care.Read more -
Advent International and PAI Partners enter into exclusive negotiations for the acquisition of IPH
The proposed transaction would create a leading European distributor of industrial supplies through the combination of Brammer and IPH.Read more -
PAI Partners enters into exclusive negotiations for the acquisition of ELITech
ELITech Group is a manufacturer of specialty in-vitro diagnostics equipment and reagents.Read more -
PAI Partners enters exclusive negotiations with Partners Group and PSP Investments for the sale of Cerba HealthCare
Under PAI Partners' ownership the business has expanded to become a European leader in clinical pathology.Read more -
Ethypharm acquires Martindale Pharma in the UK
Martindale Pharma is a leading UK-based specialty pharmaceutical company providing essential medicines to over 50 countries around the world. The company specializes in the field of opioid addiction, emergency care and sterile injectables.Read more -
PAI Partners and Goldman Sachs agree sale of the Xella Group to Lone Star
Read more -
Roompot Vakanties to be sold to PAI Partners
The acquisition will enable Roompot to further grow its position as the largest provider of quality recreational accommodations in the Netherlands and accelerate the implementation of its development plan.Read more -
PAI Partners has signed an agreement to acquire Ethypharm
Ethypharm is a leading European specialty pharma focusing on growing end-markets such as the treatment of pain and addictions. With a presence in France, Germany, the UK, Canada, the US and China, Ethypharm generates over €200 million in sales.Read more -
PAI Partners enters into an agreement to purchase Atos Medical
Atos Medical develops, manufactures and sells a range of products that help patients who have undergone total laryngectomy to restore their ability to speak and increase their quality of life.Read more